Evidence map›Paper›PMID 27252911›Full record

ArticleIranian journal of public health2016

Economic Evaluation of Health Services Costs During Pandemic Influenza A (H1N1) Pdm09 Infection in Pregnant and Non-Pregnant Women in Spain.

María Morales-Suárez-Varela, Agustín Llopis-González, Fernando González-Candela, Jenaro Astray, Jordi Alonso, Olatz Garin, Ady Castro, Juan Carlos Galan, Nuria Soldevila, Jesús Castilla and 9 more

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

María Morales-Suárez-VarelaUnit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, 46010 Valencia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Center for Public Health Research (CSISP-FISABIO), Valencia, Spain.
Agustín Llopis-GonzálezUnit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, 46010 Valencia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Center for Public Health Research (CSISP-FISABIO), Valencia, Spain.
Fernando González-CandelaCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Research Unit "Genomics and Health" CSISP-University of Valencia, Spain.
Jenaro AstraySurveillance Branch, Community of Madrid, Spain.
Jordi AlonsoCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; University Pompeu Fabra, Barcelona, Spain; Institute for Research IMIM-Hospital del Mar, Spain.
Olatz GarinCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; University Pompeu Fabra, Barcelona, Spain; Institute for Research IMIM-Hospital del Mar, Spain.
Ady CastroCIBER Respiratory Diseases, Spain.
Juan Carlos GalanCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Ramón y Cajal University Hospital, Madrid, Spain.
Nuria SoldevilaCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; University of Girona, Spain.
Jesús CastillaCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Public Health Institute of Navarra, Spain.
Pere GodoyCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Dept. of Health, Generalitat of Catalonia, Spain.
Miguel Delgado-RodríguezCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; University of Jaen, Spain.
Vicente MartinCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; University of León, Spain.
Jose María MayoralSecurity Service of Andalusia, Spain.
Tomas PumarolaRed Española de Investigación en Patología Infecciosa (REIPI), Spain.
José Maria QuintanaCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Basque Fundation for Health Innovation and Research, Spain.
Sonia TamamesDept. of Public Health, Development and Innovation, Junta de Castilla y León, Spain.
Nuria Rubio-LópezUnit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, 46010 Valencia, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Center for Public Health Research (CSISP-FISABIO), Valencia, Spain.
Angela DominguezCIBER Epidemiologia y Salud Pública (CIBERESP), Spain; Dept. of Public Health, University of Barcelona, Spain.
Universitat de València · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESRed Espanola de Investigacion en Patologia Infecciosa · ESUniversidad de Jaén · ESUniversitat de Barcelona · ESUniversity of Girona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe healthcare and socio-economic burden resulting from influenza A (H1N1) pdm09 in Spain was considerable. Our aim was to estimate and compare the management (resource utilization) and economic healthcare impact in an at-risk group of unvaccinated pregnant women with an unvaccinated group of non-pregnant woman of childbearing age (15-44 yr old).

methodsWe addressed this question with a longitudinal, observational, multicentre study. Inputs were the requirements in managing both groups of women. Outcome measures were healthcare costs. Direct healthcare (including medical utilisation, prescriptions of antivirals, medication, diagnostic tests, and hospitalisation) costs and indirect (productivity loss) costs were considered. Unit of cost was attributed to the frequency of health service resources utilisation. The mean cost per patient was calculated in this group of women.

resultsWe found that the influenza clinical pattern was worse in non-pregnant women as they had a high medical risk of 20.4% versus 6.1% of pregnant women. Non-pregnant required more antipyretics and antibiotics, and needed more health service resource utilisation (338 medical visits in non-pregnant women vs. 42 in pregnant women). The total cost of non-pregnant women was higher (€4,689.4/non-pregnant and €2,945.07/pregnant).

conclusionsCost per (H1N1) pdm09 was lower for pregnant women, probably due to more preventive measures adopted for their protection in Spain. The highest costs were incurred by hospitalisations/day and work absenteeism for non-pregnant than for pregnant women. These data will allow better future pandemic influenza planning.

Indexed as

CostsHealth servicesPandemic influenza A (H1N1)Pregnant womenSpain

Identifiers

PMID27252911
PMCPMC4888169
OpenAlexW2344787223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.